Cargando…

Use of Oral Furosemide in Hemodialysis

Detalles Bibliográficos
Autores principales:	Siga, Esteban, Alcuaz, Romina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832059/ https://www.ncbi.nlm.nih.gov/pubmed/36644352 http://dx.doi.org/10.1016/j.ekir.2022.10.025

Ejemplares similares

Response to “Use of Oral Furosemide in Hemodialysis”
por: Flythe, Jennifer E., et al.
Publicado: (2022)

Twice-weekly hemodialysis in the time of COVID-19: a multicenter study in prevalent patients
por: Siga, Esteban, et al.
Publicado: (2021)

Migraine with Persistent Visual Aura: Response to Furosemide
por: de Almeida, Roldão Faleiro, et al.
Publicado: (2009)

Feasibility of Twice-Weekly Hemodialysis During COVID-19
por: Siga, Esteban
Publicado: (2021)

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot Study
por: Flythe, Jennifer E., et al.
Publicado: (2022)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Oyama, Mark A., et al.
Publicado: (2021)

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012)

Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Atkins, Clarke, et al.
Publicado: (2021)

Effectiveness of inhaled furosemide for acute asthma exacerbation: a meta-analysis
por: Inokuchi, Ryota, et al.
Publicado: (2014)

Response to letter to editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Wess, Gerhard, et al.
Publicado: (2021)

Response to letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Wess, Gerhard, et al.
Publicado: (2021)

Optimized furosemide taste masked orally disintegrating tablets
por: Ibrahim, Mohamed Abbas, et al.
Publicado: (2017)

Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide
por: Chapa, Revathi, et al.
Publicado: (2020)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
por: Park, Sun-Hee
Publicado: (2018)

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Vitamin D deficiency in hemodialysis
por: Joob, Beuy, et al.
Publicado: (2012)

Well-being in Hemodialysis Patients
por: SERAJI, Maryam, et al.
Publicado: (2018)

COVID 19 and Hemodialysis Anxiety
por: Patel, Mohan P., et al.
Publicado: (2020)

Bacteraemia by Achromobacter denitrificans in Hemodialysis
por: Chávez-Valencia, Venice, et al.
Publicado: (2021)

Dyella japonica Bacteremia in Hemodialysis Patient
por: Kiratisin, Pattarachai, et al.
Publicado: (2007)

Comment on “The Effects of Hemodialysis on Tear Osmolarity”
por: Ayyildiz, Onder, et al.
Publicado: (2016)

Colonic Ulcerations in a Patient on Hemodialysis
por: Birajdar, N., et al.
Publicado: (2018)

New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
por: Escudero, Victor Joaquin, et al.
Publicado: (2022)

Occult hepatitis B infection in chronic hemodialysis patients: Comparison of results and concepts: Occult HBV in chronic hemodialysis patients
por: Ramezani, Amitis, et al.
Publicado: (2011)

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion
por: Dahiya, Garima, et al.
Publicado: (2022)

FRI158 Efficacy Of Oral Furosemide Test For Primary Aldosteronism Diagnosis
por: de Freitas, Thaís Castanheira, et al.
Publicado: (2023)

COVID-19 Vaccination in Hemodialysis Patients Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Is it possible to predict the length of time on continuous hemodialysis?
por: da Luz, Lucas Gobetti, et al.
Publicado: (2022)

Tuberculosis in Hemodialysis: Catch me if you can
por: Asserraji, Mohammed, et al.
Publicado: (2022)

Viral Hepatitis and HIV Infection in Hemodialysis Patients
por: Aghakhani, Arezoo, et al.
Publicado: (2012)

Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients
por: Iwamoto, Jun
Publicado: (2012)

Significant Effect of Raloxifene on Bone in Hemodialysis Patients
por: Ravn, Pernille
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j2rb5agdj8on28guogtg1a99j1